Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Another patent action

<< Previous

Bullboard Posts

Next >>

Post by Pandoraon Aug 23, 2020 12:54am

544 Views

Post# 31442813

Another patent action

Another Sherri McFarland patent is progressing. There must be a subtle difference with the other two and somebody on here probably knows what that might be.

The other two that were discussed the other day (same patent - one was a renewal of the other) were titled "Metal Based Thiopene Photodynamic Compounds and Their Use" while this one is "Metal Based Coordination Complexes as Photodynamic Compounds and Their Use."

Transaction History

Application Is Considered Ready for Issue

Date	Transaction Description
08-20-2020	Email Notification
08-19-2020	Issue Notification Mailed
07-27-2020	Dispatch to FDC
07-27-2020	Email Notification
07-27-2020	Printer Rush- No mailing
07-27-2020	Mailing Corrected Notice of Allowability
07-22-2020